Impaired parasympathetic function increases susceptibility to inflammatory bowel disease in a mouse model of depression
about
Mechanism-Oriented Therapy of Irritable Bowel SyndromeDiagnosis and management of functional symptoms in inflammatory bowel disease in remissionThe Neuromodulation of the Intestinal Immune System and Its Relevance in Inflammatory Bowel DiseaseThe vagus nerve in appetite regulation, mood and intestinal inflammationIBS-like symptoms in patients with ulcerative colitisReflex control of immunityAutonomic effects of music in health and Crohn's disease: the impact of isochronicity, emotional valence, and tempoStress and food allergy: mechanistic considerations.Considering the Bidirectional Pathways Between Depression and IBD: Recommendations for Comprehensive IBD Care.Neuronal and nonneuronal cholinergic structures in the mouse gastrointestinal tract and spleenTricyclic antidepressants for management of residual symptoms in inflammatory bowel disease.Assessment of causal link between psychological factors and symptom exacerbation in inflammatory bowel disease: a protocol for systematic review of prospective cohort studiesA magic pill? A qualitative analysis of patients' views on the role of antidepressant therapy in inflammatory bowel disease (IBD).Chronic social defeat stress disrupts regulation of lipid synthesisSerotonin activates dendritic cell function in the context of gut inflammation.β-Caryophyllene inhibits dextran sulfate sodium-induced colitis in mice through CB2 receptor activation and PPARγ pathway.Psychosocial stress in pregnancy and preterm birth: associations and mechanisms.Maternal Deprivation of Lewis Rat Pups Increases the Severity of Experi-mental Periodontitis in Adulthood.Cognitive-behavioural therapy has no effect on disease activity but improves quality of life in subgroups of patients with inflammatory bowel disease: a pilot randomised controlled trialEffect of 2 psychotherapies on depression and disease activity in pediatric Crohn's diseaseCholinergic control of inflammationMechanisms by which Stress Affects the Experimental and Clinical Inflammatory Bowel Disease (IBD): Role of Brain-Gut Axis.Efficacy of duloxetine add on in treatment of inflammatory bowel disease patients: A double-blind controlled study.Effect of venlafaxine on experimental colitis in normal and reserpinised depressed rats.Salvianolic Acid B Restored Impaired Barrier Function via Downregulation of MLCK by microRNA-1 in Rat Colitis ModelInflammation, sanitation, and consternation: loss of contact with coevolved, tolerogenic microorganisms and the pathophysiology and treatment of major depression.Fetal cholinergic anti-inflammatory pathway and necrotizing enterocolitis: the brain-gut connection begins in uteroCentral cholinergic activation of a vagus nerve-to-spleen circuit alleviates experimental colitis.Alpha7 nicotinic receptors as novel therapeutic targets for inflammation-based diseases.The vagal innervation of the gut and immune homeostasisThe intestinal cholinergic anti-inflammatory pathway.Plasticity of neuroeffector transmission during bowel inflammation1.Beneficial Effects of Maprotiline in a Murine Model of Colitis in Normal and Reserpinised Depressed Rats.99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: psycho-neuroimmunology and the intestinal microbiota: clinical observations and basic mechanisms.The Gut's Little Brain in Control of Intestinal Immunity.Early life adversity in piglets induces long-term upregulation of the enteric cholinergic nervous system and heightened, sex-specific secretomotor neuron responses.Vagotomy affects the development of oral tolerance and increases susceptibility to develop colitis independently of the alpha-7 nicotinic receptor.Anti-inflammatory Effect of Amitriptyline on Ulcerative Colitis in Normal and Reserpine-Induced Depressed Rats.5-HT3 receptors promote colonic inflammation via activation of substance P/neurokinin-1 receptors in dextran sulphate sodium-induced murine colitis.Exacerbation of DSS-induced colitis in mice lacking kinin B(1) receptors through compensatory up-regulation of kinin B(2) receptors: the role of tight junctions and intestinal homeostasis.
P2860
Q26747875-F6BBBA29-C0E5-4DF6-B73C-88CA83CED109Q26768264-F4115DC4-92AC-45A3-9515-7CEE335E840AQ26774660-6C6346C8-3F83-4E30-971F-D7E191E695FAQ28070016-F7A5F0FF-E13C-474A-B7D9-D75B9E6613B6Q28088663-504E7A61-99DE-4D73-9427-4CD302583904Q28245909-CE3D5F42-DB27-4DBE-9547-AC6233FC015AQ30374507-FA78BEEF-5E2C-4AF5-B072-7E80FF0AF195Q30423305-9F522322-87DB-4862-91BA-E11A2529AED3Q33711403-E3EE0BC5-DA41-4056-BE91-389E8D4A24C5Q33844467-29042AFA-6413-4AE6-9E4C-9A8682C0B5DFQ33951233-4856BC81-E906-4F40-A5E9-77F7AD831D14Q34035245-C4F86E65-DAC7-43C1-960B-4F8CDD35CB5FQ34346142-6D52CB88-49C4-4B1F-B7AE-B3DFF6D0CC54Q34559843-8B93C721-8755-4818-B15C-77F2E36082F3Q34756256-BB75E453-BCB1-4F98-B660-BC1DA83BA17CQ34760736-8334B45B-A157-4124-9573-8A67E4A286E1Q35038601-50481ACC-178F-4E48-94E4-F59814E67F89Q35098713-B40CF7B5-1639-4B3C-9A22-B775DCA99ED0Q35595081-34BBEF8B-FF4A-418F-8AFF-4527D812C018Q35624810-E14D7B4F-FA29-45E7-B748-2099180CB6DCQ35966390-C09E7384-5CC8-4C57-A6FA-A603ADC230A2Q35978440-B9F5D396-0EA3-4E3C-98BA-C45377279018Q36210044-A858F3B3-BF79-4E1F-B3AE-0245A58796BEQ36216726-711DB62F-A180-4D22-98CC-E2DDFF88D8A4Q36936381-23A533B8-2345-4128-820B-CA8C32FF1B86Q37047749-A76B99A2-9FA8-4915-8FFE-78F1462A0CC7Q37080684-A7A42196-BD24-41EF-AE62-33AAD8C88CAAQ37384908-45CAEFD2-965B-4085-9449-A1C80C99C784Q37800819-346D3EAF-6FF2-459E-9877-E46A90305BC4Q38047774-29371F67-38C2-422E-8EAE-DD4E9BADB1ADQ38767031-8497B43F-B887-4BBE-99FD-1E8067E31209Q39084412-E4A64E0E-AC79-46D0-88DD-B7379CEBA89EQ39646523-846B99BD-009A-456C-98A4-329BB2497D10Q39880007-35BA75AD-4713-40C7-894D-4A5B9B8A6AA7Q40566816-61E92B38-569C-4661-A87E-EBED1D8CFDCBQ40961305-8EBF1AD4-E968-4EF8-A46E-2C7897E4EE0DQ41517533-ECE2FEAD-5BBA-4442-962C-2AF81275CE26Q42087210-C8EF25D0-297B-44F6-A182-B12B9837FDDFQ42244233-22F3CD9A-AD48-45DD-B410-B06EB48A4D87Q42271585-4404939F-20AD-49A6-9392-58239D42983C
P2860
Impaired parasympathetic function increases susceptibility to inflammatory bowel disease in a mouse model of depression
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Impaired parasympathetic funct ...... in a mouse model of depression
@ast
Impaired parasympathetic funct ...... in a mouse model of depression
@en
type
label
Impaired parasympathetic funct ...... in a mouse model of depression
@ast
Impaired parasympathetic funct ...... in a mouse model of depression
@en
prefLabel
Impaired parasympathetic funct ...... in a mouse model of depression
@ast
Impaired parasympathetic funct ...... in a mouse model of depression
@en
P2860
P356
P1476
Impaired parasympathetic funct ...... in a mouse model of depression
@en
P2093
Patricia Blennerhassett
Stephen M Collins
P2860
P304
P356
10.1172/JCI32849
P407
P577
2008-06-01T00:00:00Z